FEATURED/ARCHIVES (29/04/24)
Antioxidant Enzymes and Weight Gain in Drug-Naive First-Episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study · August 2022
Articles
NCBI>Current Neuropharmacology
An Open-Label Trial on the Efficacy and Tolerability of Naltrexone/Bupropion SR for Treating Altered Eating Behaviours and Weight Loss in Binge Eating Disorder · April 2020
Abstracts
Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity
Plasma Concentrations of SSRI/SNRI After Bariatric Surgery and the Effects on Depressive Symptoms · April 2023
Articles
Frontiers in Psychiatry
A Double-Blind, Placebo-Controlled Trial of Bupropion Add-On to Olanzapine or Risperidone in Overweight Individuals with Schizophrenia · November 2021
Abstracts
Journal of Clinical Psychopharmacology
Effect of Bifidobacterium on Olanzapine-Induced Body Weight and Appetite Changes in Patients with Psychosis · May 2021
Abstracts
Psychopharmacology
Predicting Antipsychotic-Induced Weight Gain in First Episode Psychosis – A Field-Wide Systematic Review and Meta-Analysis of Non-Genetic Prognostic Factors · June 2023
Articles
European Psychiatry
Association between Antipsychotic Medication and Clinically Relevant Weight Change: Meta-Analysis · January 2023
Articles
BJPsych Open
Metabolic Biomarkers of Risperidone-Induced Weight Gain in Drug-Naive Patients with Schizophrenia · April 2023
Articles
Frontiers in Psychiatry
Naltrexone + Bupropion Combination for the Treatment of Binge-Eating Disorder with Obesity: A Randomized, Controlled Pilot Study · November 2020
Articles (Manuscripts-Versions)
PubMed Central>Clinical Therapeutics
Risperidone-Induced Obesity in Children and Adolescents with Autism Spectrum Disorder: Genetic and Clinical Risk Factors · November 2020
Articles
Frontiers in Pharmacology
Metformin Attenuates Liver Fat Content: Finding from Schizophrenia Patients with Olanzapine-Induced Weight Gain · February 2020
Articles
Clinical Psychopharmacology and Neuroscience
The Association between BDNF Levels and Risperidone-Induced Weight Gain Is Dependent on the BDNF Val66Met Polymorphism in Antipsychotic-Naive First Episode Schizophrenia Patients: A 12-Week Prospective Study · September 2021
Articles
Translational Psychiatry
Comparison of Olanzapine-Induced Weight Gain and Metabolism Abnormalities between Topiramate and Vitamin C in Patients with Schizophrenia: A Preliminary Study · May 2023
Articles
Frontiers in Psychiatry
Impacts of Metabolic Disruption, Body Mass Index and Inflammation on Cognitive Function in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine · February 2024
Articles
Annals of General Psychiatry
Psychiatric Safety and Weight Loss Efficacy of Naltrexone/Bupropion as Add-On to Antidepressant Therapy in Patients with Obesity or Overweight · April 2021
Articles
Journal of Affective Disorders
Opioid Antagonism Mitigates Antipsychotic-Associated Weight Gain: Focus on Olanzapine · March 2022
Articles
CNS Spectrums
A Systematic Review of Clinical Trials on Lumateperone and Its Effects on Body Weight · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention: A Randomized Clinical Trial · September 2022
Articles
Mayo Clinic Proceedings: Innovations, Quality and Outcomes
Olanzapine/Samidorphan Combination Consistently Mitigates Weight Gain Across Various Subgroups of Patients · October 2022
Articles
CNS Spectrums
Olanzapine and Weight Loss in Early-Onset Schizophrenia · April 2023
Articles
Primary Care Companion for CNS Disorders